ArticleStroke (Hoboken, N.J.)2022
Transcranial Doppler After Endovascular Treatment to Evaluate Collateral Status and Outcomes in Patients With Large-Vessel Occlusion.
Article in Stroke (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Transcranial doppler (TCD) in predicting outcomes following successful mechanical thrombectomy of large vessel occlusions in anterior circulation: a systematic review and meta-analysis.Journal of neurointerventional surgery · 2025Pooled it
- Association of Early M2 Pulsatility Index Ratio With Outcomes After Successful Endovascular Thrombectomy.Journal of neuroimaging : official journal of the American Society of NeuroimagingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recent advances in endovascular therapy (EVT) have led to significant improvements in functional outcomes of patients with stroke. However, early neurological deterioration after EVT has remained a concerning issue. This cohort study was designed to assess the feasibility of early transcranial Doppler (TCD) after EVT and to identify associations between TCD findings and early neurological deterioration. Methods: Between October 16, 2020, and March 28, 2021, we recruited 20 patients with acute ischemic stroke with large-vessel occlusion who underwent EVT. Five patients were excluded because of a poor temporal window; 2 had an unsuccessful intervention. Using TCD, we measured peak systolic velocity, end-diastolic velocity, mean flow velocity, and pulsatility index for all selected arteries before and within 60 minutes after EVT. We also examined the association between active leptomeningeal collateral flow after EVT and early neurological deterioration. Patients were followed for 3 months, and disability was measured using the modified Rankin scale. Results: Two patients had early neurological deterioration with elevated blood pressure and active leptomeningeal flow despite successful EVT. Most patients with poststroke disability (modified Rankin scale>2) had either flow diversion or active leptomeningeal collateral flow in the presence of elevated blood pressure (≥170/93 mm Hg). In cases without early neurological deterioration and in those with a modified Rankin scale<2, we did not observe any flow diversion or active leptomeningeal collateral. They also had a blood pressure of ≤155/85 mm Hg after EVT. All patients with hemorrhagic transformation had evidence of hyperemia on TCD. Conclusions: Early TCD is a feasible and safe approach to evaluate cerebral blood flow before and after EVT and identify those at risk of early neurological deterioration. For the next phase of this study, we plan to manage blood pressures based on individualized cerebral flow and the presence of active collateral arteries after EVT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.